Login Register Cart 0
Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Short Communication

Risk Prediction of Type 2 Diabetes Mellitus (T2DM) in Indian Families Using Antioxidant Gene Variants

Author(s): Atar Singh Kushwah, Pushpank Vats, Kauser Usman and Monisha Banerjee*

Volume 19, Issue 2, 2022

Published on: 15 December, 2022

Page: [100 - 111] Pages: 12

DOI: 10.2174/1875692120666221124121316

Price: $65

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) is a complex metabolic disease that is caused by insulin dysfunction. It is an output of oxidative stress that results from defective redox reactions and increased Reactive Metabolites (RMs) and is neutralized by antioxidant enzymes. It has been reported that decreased levels of antioxidant enzymes are due to genetic alterations in the respective genes. Therefore, the present study has undertaken a genetic analysis of antioxidant genes and their interaction in the family to assess T2DM risk.

Objective: This study aimed to investigate the individual susceptibility/risk to T2DM using antioxidant gene variants and their interactions in family members with a diabetic history.

Methods: Genotypic analysis of antioxidant genes was done by polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP), haplotype analysis, and gene-gene interactions using statistical tools. Pedigrees were constructed by face-to-face interviews with members of nine families.

Results: Genotypes AT (CAT-21A>T), IV (GSTP1+313(105I>V), and CT (GPx1 +599C>T) were found to be frequent in diabetic individuals. For instance, in one family, if only the mother had diabetes, all siblings were found to have the risk genotypes AT (CAT- 21A>T) and CT (GPx1 +599C>T) with 2.12- and 2.11-folds risk of developing T2DM. The risk haplotypes, NNV (GSTM1 N>P(Null>Present), GSTT1 N>P(Null>Present), GSTP1105I>V and TCC (CAT-21A>T, SOD2+47C>T, GPx1+599C>T) were observed in most of the diabetic individuals and non-diabetics possessing the risk haplotypes manifested altered BMI.

Conclusion: The present study suggests that the GSTP1105I>V, CAT-21A>T, SOD2+47C>T and GPx1+599C>T gene variants can be prognostic biomarkers for the assessment of T2DM risk in healthy individuals.

Next »
[1]
Banerjee M, Vats P. Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus. Redox Biol 2014; 2: 170-7.
[http://dx.doi.org/10.1016/j.redox.2013.12.001] [PMID: 25460725]
[2]
Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119.
[http://dx.doi.org/10.1016/j.diabres.2021.109119] [PMID: 34879977]
[3]
Zaki MA, Moghazy TF, El-Deeb MMK, Mohamed AH, Mohamed NAA. Glutathione S-transferase M1, T1 and P1 gene polymorphisms and the risk of developing type 2 diabetes mellitus in Egyptian diabetic patients with and without diabetic vascular complications. Alex J Med 2015; 51(1): 73-82.
[http://dx.doi.org/10.1016/j.ajme.2014.03.003]
[4]
Tala ZZ, Sari MI. Role of glutathione S-transferase Mu 1 and glutathione S-transferases theta 1 polymorphism in the risk of developing type 2 diabetes mellitus at universitas sumatera utara hospital, Medan. Open Access Maced J Med Sci 2021; 9(A): 1240-4.
[5]
Vats P, Sagar N, Singh TP, Banerjee M. Association of Superoxide dismutases (SOD1 and SOD2) and Glutathione peroxidase 1 (GPx1) gene polymorphisms with Type 2 diabetes mellitus. Free Radic Res 2015; 49(1): 17-24.
[http://dx.doi.org/10.3109/10715762.2014.971782] [PMID: 25283363]
[6]
Shen F, Liu D. The effects of cytokine polymorphisms on predisposition to microvascular complications of diabetes mellitus: A meta-analysis. Int Arch Allergy Immunol 2021; 182(11): 1103-12.
[http://dx.doi.org/10.1159/000508307] [PMID: 34583360]
[7]
Hung RJ, Boffetta P, Brockmöller J, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis 2003; 24(5): 875-82.
[http://dx.doi.org/10.1093/carcin/bgg026] [PMID: 12771031]
[8]
Tabatabaei-Malazy O, Khodaeian M, Bitarafan F, Larijani BM, Amoli M. Polymorphisms of antioxidant genes as a target for diabetes management. Int J Mol Cell Med 2017; 6(3): 135-47.
[PMID: 29682485]
[9]
Banerjee M, Vats P, Kushwah AS, Srivastava N. Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus. Br J Biomed Sci 2019; 76(4): 166-71.
[http://dx.doi.org/10.1080/09674845.2019.1595869] [PMID: 30900957]
[10]
Arab Sadeghabadi Z, Abbasalipourkabir R, Mohseni R, Ziamajidi N. Investigation of oxidative stress markers and antioxidant enzymes activity in newly diagnosed type 2 diabetes patients and healthy subjects, association with IL-6 level. J Diabetes Metab Disord 2019; 18(2): 437-43.
[http://dx.doi.org/10.1007/s40200-019-00437-8] [PMID: 31890669]
[11]
American Diabetes Association. Standards of medical care in diabetes - 2017 abridged for primary care providers. Clinical diabetes: A publication of the American Diabetes Association 2017; 35(1): 25-6.
[12]
ICMR. Guidelines for management of type 2 diabetes 2018. Available from: main.icmr.nic.in (Accessed on 30.07.2022).
[13]
Gautam S, Banerjee M. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol Genet Metab 2011; 102(4): 389-98.
[http://dx.doi.org/10.1016/j.ymgme.2010.12.012] [PMID: 21262584]
[14]
Raza S, Abbas S, Ahmad A, Ahmed F, Zaidi Zh, Mahdi F. Association of glutathione-S-transferase (GSTM1 and GSTT1) and FTO gene polymorphisms with type 2 diabetes mellitus cases in Northern India. Balkan J Med Genet 2014; 17(1): 47-54.
[http://dx.doi.org/10.2478/bjmg-2014-0027] [PMID: 25741215]
[15]
Azarova I, Bushueva O, Konoplya A, Polonikov A. Glutathione S-transferase genes and the risk of type 2 diabetes mellitus: Role of sexual dimorphism, gene-gene and gene-smoking interactions in disease susceptibility. J Diabetes 2018; 10(5): 398-407.
[http://dx.doi.org/10.1111/1753-0407.12623] [PMID: 29111615]
[16]
Banerjee M, Bid HK, Konwar R, Saxena M, Chaudhari P, Agrawal CG. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med 2010; 56(3): 176-81.
[http://dx.doi.org/10.4103/0022-3859.68633] [PMID: 20739761]
[17]
Zhang JX, Wang ZM, Zhang JJ, Zhu LL, Gao XF, Chen SL. Association of glutathione peroxidase-1 (GPx-1) rs1050450 Pro198Leu and Pro197Leu polymorphisms with cardiovascular risk: A meta-analysis of observational studies. J Geriatr Cardiol 2014; 11(2): 141-50.
[PMID: 25009565]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy